- Home
- MSM vs VKTX Comparison
MSM vs VKTX Comparison
Compare MSM & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSM | VKTX |
|---|---|---|
| Founded | 1941 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.1B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MSM | VKTX |
|---|---|---|
| Price | $106.72 | $31.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $96.20 | $95.86 |
| AVG Volume (30 Days) | 519.4K | ★ 2.2M |
| Earning Date | 04-01-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $3,363,817,000.00 | N/A |
| Revenue This Year | $5.82 | N/A |
| Revenue Next Year | $5.26 | N/A |
| P/E Ratio | $63.17 | ★ N/A |
| Revenue Growth | ★ 4.99 | N/A |
| 52 Week Low | $77.78 | $22.96 |
| 52 Week High | $107.99 | $43.15 |
Technical Indicators
Market Signals| Indicator | MSM | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 68.36 | 43.67 |
| Support Level | $82.88 | $30.30 |
| Resistance Level | N/A | $36.09 |
| Average True Range (ATR) | 2.66 | 1.66 |
| MACD | 0.38 | -0.11 |
| Stochastic Oscillator | 91.37 | 42.06 |
Price Performance
Historical ComparisonAbout MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.